CIBC Private Wealth Group
IART icon

CIBC Private Wealth Group’s Integra LifeSciences IART Stock Holding History

CIBC Private Wealth Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$199 Buy
+16
New +$213 ﹤0.01% 3217
2025
Q2 		– Sell
-58
Closed -$1.05K – 3190
2025
Q1 		$1.05K Buy
+58
New +$1.36K ﹤0.01% 2800
2024
Q2 		– Sell
-56
Closed -$1.94K – 3215
2024
Q1 		$1.94K Buy
+56
New +$2.24K ﹤0.01% 2759

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

CIBC Private Wealth Group's IART Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Integra LifeSciences (IART) in Q4 2025: 16 shares worth $199. The stake represents ﹤0.01% of the portfolio and ranks #3217 among its holdings. This is a return to the name: CIBC Private Wealth Group previously reported a position in IART as recently as Q1 2025.

CIBC Private Wealth Group first reported a position in IART in Q1 2024 and has held it in 3 quarters since. The position peaked at $1.94K in Q1 2024. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

  • CIBC Private Wealth Group held 16 shares of Integra LifeSciences worth $199 as of Q4 2025.
  • Integra LifeSciences was a new CIBC Private Wealth Group position in Q4 2025.
  • Integra LifeSciences made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3217 holding.
  • CIBC Private Wealth Group first reported a position in Integra LifeSciences in Q1 2024 and has held it in 3 quarters since.
  • CIBC Private Wealth Group's Integra LifeSciences position peaked at $1.94K in Q1 2024.
  • 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.